Gregory Gene Freitag
Chief Executive Officer, Axogen, Inc.
Companies
- ZyVersa Therapeutics, Inc.Board member Jan 17, 2023 to now1
- PDS Biotechnology CorpBoard member Mar 25, 2019 to now2
- Axogen, Inc.Board member Jun 1, 2010 to Jun 6, 20243
- Axogen, Inc.General counsel Dec 31, 2014 to Jun 1, 20204
- Axogen, Inc.Chief financial officer Jun 1, 2010 to Dec 30, 20153
- PRESSURE BIOSCIENCES INCBoard member Jul 29, 2010 to Apr 10, 20125
- Axogen, Inc.Chief executive officer Jun 1, 2010 to Jun 1, 20103
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Axogen, Inc. AXGN283,498 shares6$9.8M at $34.62Jun 4, 2024
- PDS Biotechnology Corp PDSB61,213 shares7$79.6K at $1.30Feb 28, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 28, 2025Bought 15,060 shares at $1.66 of PDS Biotechnology Corp7
- Jun 4, 2024Exercised options 11,904 shares of Axogen, Inc.6
- Mar 7, 2024Sold 25,000 shares at $9.00 of Axogen, Inc.8
- Jun 1, 2023Exercised options 6,459 shares of Axogen, Inc.9
- Jun 1, 2023Sold 29,480 shares at $8.74 of Axogen, Inc.9
- Jun 1, 2023Sold 12,500 shares at $8.65 of Axogen, Inc.9
- May 23, 2023Sold 4,640 shares at $9.26 of Axogen, Inc.10
- May 23, 2023Sold 2,828 shares at $9.17 of Axogen, Inc.10
- Nov 14, 2022Sold 13,000 shares at $12.74 of Axogen, Inc.11
- Nov 8, 2022Sold 13,000 shares at $12.50 of Axogen, Inc.12
- Aug 10, 2022Sold 8,886 shares at $9.70 of Axogen, Inc.13
- Aug 8, 2022Sold 13,046 shares at $10.37 of Axogen, Inc.14
- Aug 4, 2022Sold 24,000 shares at $10.64 of Axogen, Inc.14
- Jul 25, 2022Shares withheld for tax 30,296 shares at $9.26 of Axogen, Inc.15
- Jul 25, 2022Exercised options 83,000 shares at $3.38 of Axogen, Inc.15
- Jun 1, 2022Exercised options 3,036 shares of Axogen, Inc.16
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARPDS Biotechnology Corp, Board member
- 3SEC EDGARAxogen, Inc., Board member
- 4SEC EDGARAxogen, Inc., General counsel
- 5
- 6
- 7
- 8SEC EDGARForm 4 filed Mar 8, 2024
- 9SEC EDGARForm 4 filed Jun 5, 2023
- 10SEC EDGARForm 4 filed May 24, 2023
- 11SEC EDGARForm 4 filed Nov 16, 2022
- 12SEC EDGARForm 4 filed Nov 10, 2022
- 13SEC EDGARForm 4 filed Aug 11, 2022
- 14SEC EDGARForm 4 filed Aug 8, 2022
- 15SEC EDGARForm 4 filed Jul 26, 2022
- 16SEC EDGARForm 4 filed Jun 3, 2022